Chambers Review

Provided by Chambers
Life Sciences - USA - Nationwide
3
Band 3
What the team is known for

Fenwick has a respected practice noted for its ability to represent life sciences companies of all sizes on a broad range of matters. The firm regularly represents clients in complex IP disputes including Hatch-Waxman litigation and trademark infringement matters. It offers additional capabilities advising on transactional mandates including public offerings and M&A, as well as patent prosecution and portfolio management.

Notable practitioners

Melanie Mayer, Matthew Rossiter and Stefano Quintini colead the department and are key contacts.

Work Highlights

Provided by Fenwick
  • Fenwick continued to represent Novo Nordisk in Hatch-Waxman patent litigation arising from ANDAs filed with the FDA by six generics, seeking approval to market generic versions of Novo Nordisk's GLP-1 diabetes treatment, Ozempic.

Strengths

Provided by Chambers